CUE vs KR · rev $9.3M vs P/E 19, rev $147.12B
Cue Biopharma (CUE) versus Kroger Company (KR) — a side-by-side from cached financials, not a winner call.
Cue Biopharma (CUE) is a biotechnology company listed on US.
Kroger Company (KR) is a grocery stores company listed on US.
Latest reported CUE revenue for 2024-12-31 was $9.3M. Net income was -$40.7M. Revenue was up 69.2% from 2023-12-31 to 2024-12-31. CUE currently screens at market cap $59.5M.
Latest reported KR revenue for 2025-02-01 was $147.12B. Net income was $2.67B. KR currently screens at market cap $46.17B and trailing P/E 19.0.
CUE currently screens at market cap $59.5M. KR currently screens at market cap $46.17B and trailing P/E 19.0.
Not investment advice. Open the CUE and KR stock pages for the full models.
Not investment advice.